295 related articles for article (PubMed ID: 23737025)
1. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
2. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
3. [Synchronous and metachronous myeloid and lymphoid tumors].
Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
[TBL] [Abstract][Full Text] [Related]
4. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
[TBL] [Abstract][Full Text] [Related]
5. The results of modern surgical therapy for multiple primary lung cancers.
Adebonojo SA; Moritz DM; Danby CA
Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
[TBL] [Abstract][Full Text] [Related]
6. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
7. Multiple primary malignancies--epidemiological analysis at a single tertiary institution.
Irimie A; Achimas-Cadariu P; Burz C; Puscas E
J Gastrointestin Liver Dis; 2010 Mar; 19(1):69-73. PubMed ID: 20361078
[TBL] [Abstract][Full Text] [Related]
8. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma and other malignancies: a pilot study from the Houston VA.
Munker R; Shi R; Lin D; Guo S; Hayes TG
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):102-6. PubMed ID: 24373789
[TBL] [Abstract][Full Text] [Related]
10. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
11. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
12. Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies.
Steinhagen E; Moore HG; Lee-Kong SA; Shia J; Eaton A; Markowitz AJ; Russo P; Guillem JG
Clin Colorectal Cancer; 2013 Mar; 12(1):23-7. PubMed ID: 23026110
[TBL] [Abstract][Full Text] [Related]
13. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
Kamp K; Damhuis RA; Feelders RA; de Herder WW
Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of synchronous second primary malignancies on the overall survival of patients with metastatic prostate cancer.
Koo KC; Yoo H; Kim KH; Park SU; Han KS; Rha KH; Hong SJ; Yang SC; Chung BH
J Urol; 2015 Apr; 193(4):1239-44. PubMed ID: 25444987
[TBL] [Abstract][Full Text] [Related]
17. Second primary lung malignancy in head and neck cancer patients.
Dequanter D; Shahla M; Lardinois I; Gilbert O; Hanquet O; Tragas G; Van Meerhæghe A; Lothaire P
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jan; 128(1):11-3. PubMed ID: 20850406
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the frequency of and survival from second primary cancers in North Portugal: a population-based study.
Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
Eur J Cancer Prev; 2013 Nov; 22(6):599-606. PubMed ID: 23462457
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.
Ghiringhelli F; Hennequin A; Drouillard A; Lepage C; Faivre J; Bouvier AM
Dig Liver Dis; 2014 Sep; 46(9):854-8. PubMed ID: 24908575
[TBL] [Abstract][Full Text] [Related]
20. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
